Delabelling beta-lactam allergy

dc.contributor.authorMolina Molina, Gustavo Jorge
dc.contributor.authorGarnica Velandia, Diana Rocío
dc.contributor.authorAndrés López, Blanca
dc.contributor.authorPerales, Carolina
dc.contributor.authorMarín Asensio, Laura
dc.contributor.authorJurgens, Yanina
dc.contributor.authorEsteso, Olga
dc.contributor.authorEscobar, Carolina
dc.contributor.authorVidal, Xavier
dc.contributor.authorVendrell, Lourdes
dc.contributor.authorGómez Ganda, Laura
dc.contributor.authorRodríguez, Dolores
dc.contributor.authorMontané, Eva
dc.contributor.authorCardona, Victoria
dc.contributor.authorAgustí, Antònia
dc.date.accessioned2024-08-29T12:35:16Z
dc.date.available2024-08-29T12:35:16Z
dc.date.issued2024-06-27
dc.date.updated2024-07-31T10:16:59Z
dc.description.abstractBackground: Hypersensitivity to beta-lactam (BL) antibiotics is one of the most frequent reported drug allergies. In our population, it is common to find labels of BL allergy in electronic medical records (EMRs) that have not been assessed. The objective of our study was to detect patients with beta-lactam allergy labels in their EMRs and to assess how many of them are false after a correct diagnostic evaluation.Methods: A multicentre prospective study was performed with patients labelled as allergic to BLs in their EMRs in the previous 5 years. Demographical and clinical data, as well as variables regarding the BL allergy label and the characteristics of the index reaction from clinical history and EMRs, were recorded. Then, diagnostic assessments including clinical history, skin tests (STs), and drug provocation tests (DPTs) were conducted in order to confirm or exclude the diagnosis of BL allergy.Results: A total of 249 patients completed the study, of which 160 (64.3%) were women with a median age of 57 years (interquartile range [IQR], 45-68). The most frequent BL allergy labels detected were for penicillin (124), amoxicillin/clavulanic acid (61), and amoxicillin (54). Of the 204 patients who underwent STs, 20.1% were positive. DPTs were performed in 224 patients, showing good tolerance in 87.1% of cases. After the allergy diagnosis work-up, 186 patients (74.7%) were diagnosed as non-allergic to BL antibiotics.Conclusion: In our study population, the number of patients labelled as allergic to BLs in their EMRs was similar to that in previously published studies, with proportions near to 75%-80% being falsely labelled as allergic to BLs.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1663-9812
dc.identifier.pmid38994200
dc.identifier.urihttps://hdl.handle.net/2445/214874
dc.language.isoeng
dc.publisherFrontiers Media SA
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fphar.2024.1423719
dc.relation.ispartofFrontiers in Pharmacology, 2024, vol. 15
dc.relation.urihttps://doi.org/10.3389/fphar.2024.1423719
dc.rightscc by (c) Molina Molina, Gustavo Jorge et al, 2024
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationAl·lèrgia als medicaments
dc.subject.classificationAntibiòtics betalactàmics
dc.subject.otherDrug allergy
dc.subject.otherBeta lactam antibiotics
dc.titleDelabelling beta-lactam allergy
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
fphar-15-1423719.pdf
Mida:
1.77 MB
Format:
Adobe Portable Document Format